SpondylolisthesisNCT02966639
Validation of Appropriateness Criteria for the Surgical Treatment of Lumbar Degenerative Spondylolisthesis
An observational study of Spondylolisthesis, run by Dartmouth-Hitchcock Medical Center at 1 site in United States.
Trial summary
The main objective of this study is the external validation of the appropriateness criteria for the surgical treatment of Lumbar Degenerative Spondylolisthesis. We will assess, prospectively, whether patients treated "appropriately" have better outcomes than those treated "inappropriately" according to the RAND… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Spondylolisthesis
- How many people
- 171 participants
- Where
- 1 siteUnited States
- Study dates
- Oct 2016to 1 Jun 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Skeletally mature individuals with a primary pathology of single-level degenerative spondylolisthesis in the lumbar region of the spine.
Who may be able to join
- Is the patient skeletally mature with a primary pathology of single level degenerative spondylolisthesis in the lumbar region of the spine (with or without stenosis at other levels)?
- Able to give written informed consent
- Patient has already undertaken a course of non-operative care
Who cannot join
- Primarily degenerative scoliosis curvature greater than 15 degrees
- Presence of Isthmic Spondylolisthesis
- Cauda equine syndrome requiring immediate emergency surgery
- Active spinal infection, tumor, or unhealed fracture
- Inability to understand English
- Patient refused to participate.
Trial locations and contacts
1 site in 1 country.
United States1 site
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, 03756
About this study
The main objective of this study is the external validation of the appropriateness criteria for the surgical treatment of Lumbar Degenerative Spondylolisthesis. We will assess, prospectively, whether patients treated "appropriately" have better outcomes than those treated "inappropriately" according to the RAND Appropriateness Method (RAM) Criteria.
Read the detailed description
Spinal stenosis is the most common reason for lumbar surgery in patients over age 65, and a substantial proportion of stenosis patients present with concomitant lumbar degenerative spondylolisthesis (LDS). This condition is characterized by the anterior translation of a vertebra due to degenerative changes in the facet joints and disk, most commonly at L4-L5, and is most prevalent in women over age 50. The translation commonly results in spinal stenosis, and patients tend to present with various combinations of low back pain, radiculopathy, and neurogenic claudication. The Spine Patient Outcomes Research Trial (SPORT) demonstrated better outcomes for patients treated with surgery compared to non-operative treatment. However, all patients met strict inclusion criteria including the presence of radicular pain or neurogenic claudication, cross-sectional imaging demonstrating spinal stenosis consistent with their symptoms, and duration of symptoms for over three months. Additionally, specific patient and disease characteristics were shown to significantly affect surgical and non-operative outcomes. While the literature makes it clear that surgery results in better outcomes than non-operative treatment for the "average" LDS patient, surgeons have to help make treatment decisions for patients with a diverse array of characteristics that can have positive and negative effects on surgical outcomes. Additionally, many LDS patients do not meet the inclusion criteria of SPORT, and extrapolating the results to these patients is inappropriate. The currently available evidence provides surgeons with some general principles to help guide decision-making but does not inform decision-making at the individual patient level.
Many studies have evaluated the effect of specific patient and disease characteristics on surgical outcomes for spinal stenosis. These have generally shown worse surgical outcomes for patients with medical and psychological comorbidities, lower socioeconomic status and educational attainment, smokers, those with predominant back pain, those receiving workers' compensation, and patients involved in litigation. However, subgroup analysis of the SPORT degenerative spondylolisthesis cohort, the first study that evaluated predictors of both surgical and non-operative LDS outcomes, demonstrated that these factors tended to predict both worse surgical and non-operative outcomes. As a result, most of these subgroups tended to have a similar treatment effect of surgery (i.e. relative advantage of surgical compared to non-operative outcomes) even if their absolute degree of improvement with surgery was less. While these data suggest that most LDS patients meeting the SPORT inclusion criteria will improve more with surgery than with non-operative treatment, many LDS patients do not meet the SPORT inclusion criteria, and evidence is needed to provide treatment guidelines for these patients.
In an ideal world, randomized-controlled trials (RCT) would be performed for multiple subgroups in order to compare outcomes among all available treatment options. The SPORT LDS RCT demonstrated the difficulty in performing a seemingly straightforward RCT comparing surgery to non-operative treatment, with only 64% of patients assigned to surgery having undergone an operation within 2 years, and 49% of patients randomized to non-operative treatment having undergone surgery by 2 years. Given that it is not possible to perform sufficiently powered RCTs to compare surgical and non-operative outcomes for multiple LDS subgroups, other methods must be considered to generate guidelines to help surgeons and LDS patients select the most appropriate treatment based on their individual characteristics. One such alternative is the RAND appropriateness method (RAM), which combines a detailed review of the literature with a modified Delphi panel approach to create appropriateness criteria based on collective expert opinion. A major strength of the RAM is that is involves a high level of clinical detail, allowing for treatment recommendations to be made based on a number of relevant patient and disease characteristics that can be applied to individual patients. The RAM has been widely used and studied by several groups in various countries in relation to different spinal problems. The RAM is considered most useful for procedures that are used frequently, associated with a substantial amount of morbidity and/or mortality, consume significant resources, have wide variation among geographic areas in rates of use, and whose use is controversial. All these criteria apply to the procedures commonly used in the surgical treatment of LDS. Depending on the definition of success, success rates at 1 year after surgery range from 50% to 94%. The rate of lumbar fusion in the United States Medicare population has been shown to vary nearly 20-fold across hospital referral regions. In the SPORT LDS cohort, significant differences were found across different study centers in patients' baseline neurological deficit, stenosis location and severity, and number of stenotic levels as well as in their functional outcome out to 4 years after surgery. High levels of geographic variation are frequently attributed to uncertainty about the most appropriate treatment for a given condition, usually reflecting a lack of strong evidence. Given the lack of treatment recommendations that can be applied at the individual LDS patient level, an international group of experts were convened to use the RAM to create appropriateness criteria for surgery for LDS.3
The RAM process included 14 experts from the USA, UK, Belgium, Sweden, Norway, Spain, Switzerland, and Hungary with backgrounds in orthopaedic surgery, neurosurgery, rheumatology, and physical medicine. The experts considered the appropriateness of decompression alone, uninstrumented fusion with or without decompression, and instrumented fusion with or without decompression for 744 patient scenarios. The variables defining the scenarios included symptomatology (back pain, radicular pain, and/or neurogenic claudication), severity of neurological deficit, presence of significant foraminal and/or central stenosis, level of disability, presence of significant medical comorbidities, clinically relevant "instability", and the presence of significant psychosocial "yellow flags". The appropriateness of each type of surgery was rated on a 1-9 scale (1-3 inappropriate, 4-6 uncertain, and 7-9 appropriate) in two separate rounds by the expert panel. Surgery of one type or another was considered appropriate in 27% of scenarios, uncertain in 41%, and inappropriate in 31%. In general, scenarios in which symptoms were limited to back pain in the absence of instability were considered inappropriate for surgery, whereas the presence of radiculopathy or claudication, neurologic deficit, and instability increased the likelihood of a scenario being considered appropriate for surgery. The presence of medical comorbidities and "yellow flags" decreased the likelihood of a scenario being considered appropriate for surgery. There was widespread disagreement about the appropriate use of instrumentation, but, in general, fusion of some variety was more likely to be considered appropriate in the presence of back pain or instability.
The RAM was successfully employed to develop appropriateness criteria for LDS surgery. Prior to widespread clinical implementation, the results need to be validated in the LDS population. If validated successfully, a computer-based algorithm could be developed to help surgeons and patients select treatment using the appropriateness criteria. This would represent a significant advancement in shared decision making for LDS, effectively moving from population-based recommendations to those that can be applied at the individual patient level.
- Conditions
- Spondylolisthesis
- Medical subject headings
- Spondylolisthesis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| LDS Patients | All patients with a diagnosis of single-level Lumbar Degenerative Spondylolisthesis who present to the DHMC Spine Center. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Core Outcome Measures Index
Measured: 12-months Post-Treatment
Secondary outcomes (5)
Oswestry Disability Index
Measured: 12-months Post-Treatment
Global Outcome of Treatment Questions
Questions with 5 response categories, dichotomized to "good" and "poor"
Measured: 12-months Post-Treatment
Satisfaction with Care
Questions with 5 response categories, dichotomized to "good" and "poor"
Measured: 12-months Post-Treatment
Complications from Treatment
Questions with 5 response categories, dichotomized to "good" and "poor"
Measured: 12-months Post-Treatment
Further Treatment after Initial Treatment
Questions with 5 response categories, dichotomized to "good" and "poor"
Measured: 12-months Post-Treatment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Nov 2016 (estimated)
- Study startOct 2016
- Primary completion1 Jun 2021
- Study completion1 Jun 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SpondylolisthesisStudies of the same condition, open and under way.
- More trials run by Dartmouth-Hitchcock Medical CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 171 participants (actual)
Sponsor and investigators
- Lead sponsor
- Dartmouth-Hitchcock Medical Center
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Adam M. Pearson, Dartmouth-Hitchcock Medical Center
- Investigators
- Adam M Pearson, MD, Principal investigator, Dartmouth-Hitchcock Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02966639
- Sponsor's protocol ID
- D16174
- Status last verified
- Aug 2021
- First submitted
- 14 Nov 2016
- Last updated
- 9 Aug 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 9 Aug 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Validation of Appropriateness Criteria for the Surgical Treatment of Lumbar Degenerative Spondylolisthesis
- ClinicalTrials.gov ID
- NCT02966639
- Acronym / sponsor ID
- D16174
- Conditions
- Spondylolisthesis
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 171 participants (actual)
- Lead sponsor
- Dartmouth-Hitchcock Medical CenterUniversity, hospital or other
- Study start
- Oct 2016 (actual)
- Primary completion
- 1 Jun 2021 (actual)
- Study completion
- 1 Jun 2021 (actual)
- First posted
- 17 Nov 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The main objective of this study is the external validation of the appropriateness criteria for the surgical treatment of Lumbar Degenerative Spondylolisthesis. We will assess, prospectively, whether patients treated "appropriately" have better outcomes than those treated "inappropriately" according to the RAND Appropriateness Method (RAM) Criteria.
Detailed description
Spinal stenosis is the most common reason for lumbar surgery in patients over age 65, and a substantial proportion of stenosis patients present with concomitant lumbar degenerative spondylolisthesis (LDS). This condition is characterized by the anterior translation of a vertebra due to degenerative changes in the facet joints and disk, most commonly at L4-L5, and is most prevalent in women over age 50. The translation commonly results in spinal stenosis, and patients tend to present with various combinations of low back pain, radiculopathy, and neurogenic claudication. The Spine Patient Outcomes Research Trial (SPORT) demonstrated better outcomes for patients treated with surgery compared to non-operative treatment. However, all patients met strict inclusion criteria including the presence of radicular pain or neurogenic claudication, cross-sectional imaging demonstrating spinal stenosis consistent with their symptoms, and duration of symptoms for over three months. Additionally, specific patient and disease characteristics were shown to significantly affect surgical and non-operative outcomes. While the literature makes it clear that surgery results in better outcomes than non-operative treatment for the "average" LDS patient, surgeons have to help make treatment decisions for patients with a diverse array of characteristics that can have positive and negative effects on surgical outcomes. Additionally, many LDS patients do not meet the inclusion criteria of SPORT, and extrapolating the results to these patients is inappropriate. The currently available evidence provides surgeons with some general principles to help guide decision-making but does not inform decision-making at the individual patient level.
Many studies have evaluated the effect of specific patient and disease characteristics on surgical outcomes for spinal stenosis. These have generally shown worse surgical outcomes for patients with medical and psychological comorbidities, lower socioeconomic status and educational attainment, smokers, those with predominant back pain, those receiving workers' compensation, and patients involved in litigation. However, subgroup analysis of the SPORT degenerative spondylolisthesis cohort, the first study that evaluated predictors of both surgical and non-operative LDS outcomes, demonstrated that these factors tended to predict both worse surgical and non-operative outcomes. As a result, most of these subgroups tended to have a similar treatment effect of surgery (i.e. relative advantage of surgical compared to non-operative outcomes) even if their absolute degree of improvement with surgery was less. While these data suggest that most LDS patients meeting the SPORT inclusion criteria will improve more with surgery than with non-operative treatment, many LDS patients do not meet the SPORT inclusion criteria, and evidence is needed to provide treatment guidelines for these patients.
In an ideal world, randomized-controlled trials (RCT) would be performed for multiple subgroups in order to compare outcomes among all available treatment options. The SPORT LDS RCT demonstrated the difficulty in performing a seemingly straightforward RCT comparing surgery to non-operative treatment, with only 64% of patients assigned to surgery having undergone an operation within 2 years, and 49% of patients randomized to non-operative treatment having undergone surgery by 2 years. Given that it is not possible to perform sufficiently powered RCTs to compare surgical and non-operative outcomes for multiple LDS subgroups, other methods must be considered to generate guidelines to help surgeons and LDS patients select the most appropriate treatment based on their individual characteristics. One such alternative is the RAND appropriateness method (RAM), which combines a detailed review of the literature with a modified Delphi panel approach to create appropriateness criteria based on collective expert opinion. A major strength of the RAM is that is involves a high level of clinical detail, allowing for treatment recommendations to be made based on a number of relevant patient and disease characteristics that can be applied to individual patients. The RAM has been widely used and studied by several groups in various countries in relation to different spinal problems. The RAM is considered most useful for procedures that are used frequently, associated with a substantial amount of morbidity and/or mortality, consume significant resources, have wide variation among geographic areas in rates of use, and whose use is controversial. All these criteria apply to the procedures commonly used in the surgical treatment of LDS. Depending on the definition of success, success rates at 1 year after surgery range from 50% to 94%. The rate of lumbar fusion in the United States Medicare population has been shown to vary nearly 20-fold across hospital referral regions. In the SPORT LDS cohort, significant differences were found across different study centers in patients' baseline neurological deficit, stenosis location and severity, and number of stenotic levels as well as in their functional outcome out to 4 years after surgery. High levels of geographic variation are frequently attributed to uncertainty about the most appropriate treatment for a given condition, usually reflecting a lack of strong evidence. Given the lack of treatment recommendations that can be applied at the individual LDS patient level, an international group of experts were convened to use the RAM to create appropriateness criteria for surgery for LDS.3
The RAM process included 14 experts from the USA, UK, Belgium, Sweden, Norway, Spain, Switzerland, and Hungary with backgrounds in orthopaedic surgery, neurosurgery, rheumatology, and physical medicine. The experts considered the appropriateness of decompression alone, uninstrumented fusion with or without decompression, and instrumented fusion with or without decompression for 744 patient scenarios. The variables defining the scenarios included symptomatology (back pain, radicular pain, and/or neurogenic claudication), severity of neurological deficit, presence of significant foraminal and/or central stenosis, level of disability, presence of significant medical comorbidities, clinically relevant "instability", and the presence of significant psychosocial "yellow flags". The appropriateness of each type of surgery was rated on a 1-9 scale (1-3 inappropriate, 4-6 uncertain, and 7-9 appropriate) in two separate rounds by the expert panel. Surgery of one type or another was considered appropriate in 27% of scenarios, uncertain in 41%, and inappropriate in 31%. In general, scenarios in which symptoms were limited to back pain in the absence of instability were considered inappropriate for surgery, whereas the presence of radiculopathy or claudication, neurologic deficit, and instability increased the likelihood of a scenario being considered appropriate for surgery. The presence of medical comorbidities and "yellow flags" decreased the likelihood of a scenario being considered appropriate for surgery. There was widespread disagreement about the appropriate use of instrumentation, but, in general, fusion of some variety was more likely to be considered appropriate in the presence of back pain or instability.
The RAM was successfully employed to develop appropriateness criteria for LDS surgery. Prior to widespread clinical implementation, the results need to be validated in the LDS population. If validated successfully, a computer-based algorithm could be developed to help surgeons and patients select treatment using the appropriateness criteria. This would represent a significant advancement in shared decision making for LDS, effectively moving from population-based recommendations to those that can be applied at the individual patient level.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| LDS Patients | – | –All patients with a diagnosis of single-level Lumbar Degenerative Spondylolisthesis who present to the DHMC Spine Center. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Skeletally mature individuals with a primary pathology of single-level degenerative spondylolisthesis in the lumbar region of the spine.
Key inclusion criteria (3 listed)
- Is the patient skeletally mature with a primary pathology of single level degenerative spondylolisthesis in the lumbar region of the spine (with or without stenosis at other levels)?
- Able to give written informed consent
- Patient has already undertaken a course of non-operative care
Key exclusion criteria (6 listed)
- Primarily degenerative scoliosis curvature greater than 15 degrees
- Presence of Isthmic Spondylolisthesis
- Cauda equine syndrome requiring immediate emergency surgery
- Active spinal infection, tumor, or unhealed fracture
- Inability to understand English
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Core Outcome Measures Index
Time frame: 12-months Post-Treatment
5 secondary outcomes
Oswestry Disability Index
Time frame: 12-months Post-Treatment
Global Outcome of Treatment Questions
Time frame: 12-months Post-Treatment
Satisfaction with Care
Time frame: 12-months Post-Treatment
Complications from Treatment
Time frame: 12-months Post-Treatment
Further Treatment after Initial Treatment
Time frame: 12-months Post-Treatment
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Aug 2021.
- Individual participant dataSharing planned: Yes
Related trials for Spondylolisthesis
Recruiting
Post-Market Clinical Study of Functional Motion Outcomes in Subjects Treated With the Minuteman Device
Degenerative Conditions of the Lumbar Spine, Lumbar Spinal Stenosis
RecruitingObservational study
Thoracic-Lumbar Arthrodesis- Implanet Jazz
Spondylolisthesis, Spinal Stenosis
Recruiting
Studying Melatonin and Recovery in Teens
Juvenile; Scoliosis, Scoliosis Idiopathic
Not yet recruiting
Kore Fiber PLF Study
Degenerative Lumbar Spine Diseases, Lumbar Degenerative Disc Disease
Active, not recruiting
SLIP II Registry: Spinal Laminectomy Versus Instrumented Pedicle Screw Fusion
Lumbar Spondylolisthesis, Grade 1 Spondylolisthesis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Adam M Pearson, MD principal investigator
Dartmouth-Hitchcock Medical Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Spondylolisthesis, run by Dartmouth-Hitchcock Medical Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Core Outcome Measures Index (time frame: 12-months Post-Treatment). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Aug 2021.